carteolol has been researched along with Contact Dermatitis in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giordano-Labadie, F | 1 |
| Lepoittevin, JP | 1 |
| Calix, I | 1 |
| Bazex, J | 1 |
1 other study available for carteolol and Contact Dermatitis
| Article | Year |
|---|---|
[Contact allergy to beta blockaders in eye drops: cross allergy?].
Topics: Adrenergic beta-Antagonists; Aged; Carteolol; Cross Reactions; Dermatitis, Contact; Eyelid Diseases; | 1997 |